POZEN to Present at the Wachovia Securities 2008 Small & Mid Cap Healthcare Conference

POZEN Inc. (NASDAQ: POZN) announced today that William L. Hodges, the company’s chief financial officer, will present at the Wachovia Securities 2008 Small & Mid Cap Healthcare Conference on Wednesday, January 30, 2008 at 11:15 a.m. (ET) at the Langham Hotel in Boston. Mr. Hodges’ presentation will be webcast and archived on POZEN’s home page at www.pozen.com.

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN’s efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline for the proposed product candidate Treximet™ which is currently under review by the United States Food and Drug Administration for the acute treatment of migraine, and with AstraZeneca for the proposed product candidate PN 400 for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The company’s common stock is traded on The Nasdaq Stock Market under the symbol “POZN”. For detailed company information, including copies of this and other press releases, see POZEN’s website: www.pozen.com.